![]() |
同义名 : | 安息香酸钠 |
CAS号 : | 532-32-1 | |
货号 : | A477289 | |
分子式 : | C7H5NaO2 | |
纯度 : | 98% | |
分子量 : | 144.1 | |
MDL号 : | MFCD00012463 | |
存储条件: |
Pure form Inert atmosphere, room temperature In solvent -20°C:3-6个月-80°C:12个月 |
|
溶解度 : | - | |
动物实验配方: |
生物活性 | |||
---|---|---|---|
描述 | Sodium benzoate, a D-amino acid oxidase (DAAO) inhibitor, improved cognitive function of early-phase Alzheimer's disease (AD) after 24-week treatment[1]. Sodium benzoate (SB) was well tolerated without evident side effects. Sodium benzoate adjuvant therapy improved symptomatology of patients with clozapine-resistant schizophrenia[2]. SB significantly impaired memory and motor coordination. Moreover, SB decreased reduced GSH (reduced glutathione) and increased the MDA (malondialdehyde) level in the brain significantly. Short-term consumption of SB can impair memory performance and increased brain oxidative stress in mice[3]. Repeated administration of sodium benzoate (400 and 800 mg/kg i.p.) and sulfasalazine (500 mg/kg orally) for 7 days, i.e. 2 days before and continued for 5 days after acetic acid infusion, significantly attenuated macroscopic damage and disease activity score as compared to disease control[4]. |
实验方案 | |||
---|---|---|---|
1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
6.94mL 1.39mL 0.69mL |
34.70mL 6.94mL 3.47mL |
69.40mL 13.88mL 6.94mL |
参考文献 |
---|